No registrations found.
ID
Source
Brief title
Health condition
-Children with mild to borderline intellectual disabilities and psychiatric problems (e.g. ADHD, autism)
Sponsors and support
Intervention
Outcome measures
Primary outcome
1) School achievements (LVS)
2) Behavioural and psychiatric symptoms (CBCL/TRF questionnaires)
Secondary outcome
1) IQ (WISC-5)
2) Measures of executive functioning (COTAPP)
Background summary
Children with intellectual disabilities and psychiatric disorders (e.g. ADHD, autism) often present themselves with a wide range of neuropsychological dysfunctions, such as impaired working memory, response inhibition, sustained attention, response variability, delay aversion and altered reward sensitivity. These dysfunctions may –in addition to the low intellectual abilities- contribute to more prominent behavioral problems and poorer learning progress. Therefore, it has been hypothesized that measuring these neuropsychological functions has added value in routine clinical practice. However, this hypothesis has not been tested. Therefore, the aim of this study was to assess the additive predictive value of executive functions beyond the predictive effect of IQ on behavioural problems and school achievements in 42 Dutch children 6-12 years old with intellectual disabilities (50
Study objective
The aim of this study is to assess the additive predictive value of neurocognitive abilities beyond the predictive effect of IQ in children (6-12 years old) with mild to borderline intellectual disabilities (50
It is hypothesized that measuring neuropsychological functions next to IQ in children with MBID and psychiatric problems has added value in routine clinical practice.
Study design
Observational study: one timepoint.
Intervention
Not applicable
Inclusion criteria
- 42 children aged 6-12 years old
- attending primary school
- (estimated) TIQ between 50 and 85
- Dutch as first language
- Diagnosed with a psychiatric disorder
Exclusion criteria
- Presence of a specific language impairment
- Psychoactive medication that requires a gradual (> 24 hours) discontinuation scheme and build up phase
- When a parent does not give permission for school to give information about school achievements
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
| Register | ID |
|---|---|
| NTR-new | NL7303 |
| NTR-old | NTR7519 |
| Other | CMO (METC) Radboud UMC Nijmegen, NL : 2018-4441 |